Distinct 3D Architecture and Dynamics of the Human HtrA2(Omi) Protease and Its Mutated Variants

HtrA2(Omi) protease controls protein quality in mitochondria and plays a major role in apoptosis. Its HtrA2S306A mutant (with the catalytic serine routinely disabled for an X-ray study to avoid self-degradation) is a homotrimer whose subunits contain the serine protease domain (PD) and the regulatory PDZ domain. In the inactive state, a tight interdomain interface limits penetration of both PDZ-activating ligands and PD substrates into their respective target sites. We successfully crystalized HtrA2V226K/S306A, whose active counterpart HtrA2V226K has had higher proteolytic activity, suggesting higher propensity to opening the PD-PDZ interface than that of the wild type HtrA2. Yet, the crystal structure revealed the HtrA2V226K/S306A architecture typical of the inactive protein. To get a consistent interpretation of crystallographic data in the light of kinetic results, we employed molecular dynamics (MD). V325D inactivating mutant was used as a reference. Our simulations demonstrated that upon binding of a specific peptide ligand NH2-GWTMFWV-COOH, the PDZ domains open more dynamically in the wild type protease compared to the V226K mutant, whereas the movement is not observed in the V325D mutant. The movement relies on a PDZ vs. PD rotation which opens the PD-PDZ interface in a lid-like (budding flower-like in trimer) fashion. The noncovalent hinges A and B are provided by two clusters of interfacing residues, harboring V325D and V226K in the C- and N-terminal PD barrels, respectively. The opening of the subunit interfaces progresses in a sequential manner during the 50 ns MD simulation. In the systems without the ligand only minor PDZ shifts relative to PD are observed, but the interface does not open. Further activation-associated events, e.g. PDZ-L3 positional swap seen in any active HtrA protein (vs. HtrA2), were not observed. In summary, this study provides hints on the mechanism of activation of wtHtrA2, the dynamics of the inactive HtrA2V325D, but does not allow to explain an increased activity of HtrA2V226K.

[1]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[2]  Z. Zhou,et al.  Activation of DegP chaperone-protease via formation of large cage-like oligomers upon binding to substrate proteins , 2008, Proceedings of the National Academy of Sciences.

[3]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[4]  Duncan Poole,et al.  Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born , 2012, Journal of chemical theory and computation.

[5]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[6]  M. Ehrmann,et al.  Structural adaptation of the plant protease Deg1 to repair photosystem II during light exposure , 2011, Nature Structural &Molecular Biology.

[7]  K. Bose,et al.  Intricate structural coordination and domain plasticity regulate activity of serine protease HtrA2 , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[9]  M. Ehrmann,et al.  Substrate-induced remodeling of the active site regulates human HTRA1 activity , 2011, Nature Structural &Molecular Biology.

[10]  J. Skorko-Glonek,et al.  HtrA proteins as targets in therapy of cancer and other diseases , 2010, Expert opinion on therapeutic targets.

[11]  R. Hilgenfeld,et al.  Architecture and regulation of HtrA-family proteins involved in protein quality control and stress response , 2012, Cellular and Molecular Life Sciences.

[12]  H. Berendsen,et al.  Essential dynamics of proteins , 1993, Proteins.

[13]  Anuradha Cholleti,et al.  Dual regulatory switch confers tighter control on HtrA2 proteolytic activity , 2014, The FEBS journal.

[14]  A. Joachimiak,et al.  Structural and Functional Analysis of Human HtrA3 Protease and Its Subdomains , 2015, PloS one.

[15]  Nitu Singh,et al.  The structural basis of mode of activation and functional diversity: a case study with HtrA family of serine proteases. , 2011, Archives of biochemistry and biophysics.

[16]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[17]  Robert Huber,et al.  Crystal structure of DegP (HtrA) reveals a new protease-chaperone machine , 2002, Nature.

[18]  R. Hilgenfeld,et al.  The Legionella HtrA homologue DegQ is a self-compartmentizing protease that forms large 12-meric assemblies , 2011, Proceedings of the National Academy of Sciences.

[19]  Tim Clausen,et al.  Crystal Structure of the DegS Stress Sensor How a PDZ Domain Recognizes Misfolded Protein and Activates a Protease , 2004, Cell.

[20]  Seongman Kang,et al.  Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi , 2004, Neuroscience Letters.

[21]  J. Chien,et al.  HtrA serine proteases as potential therapeutic targets in cancer. , 2009, Current cancer drug targets.

[22]  S. Sidhu,et al.  Structural and functional analysis of the ligand specificity of the HtrA2/Omi PDZ domain , 2007, Protein science : a publication of the Protein Society.

[23]  C. Georgopoulos,et al.  The HtrA (DegP) protein, essential for Escherichia coli survival at high temperatures, is an endopeptidase , 1990, Journal of bacteriology.

[24]  C. Craik,et al.  Evolutionary Divergence of Substrate Specificity within the Chymotrypsin-like Serine Protease Fold* , 1997, The Journal of Biological Chemistry.

[25]  Tim Clausen,et al.  Molecular Adaptation of the DegQ Protease to Exert Protein Quality Control in the Bacterial Cell Envelope* , 2011, The Journal of Biological Chemistry.

[26]  H. Saibil,et al.  Structural basis for the regulated protease and chaperone function of DegP , 2008, Nature.

[27]  Owen Johnson,et al.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM , 2011, Acta crystallographica. Section D, Biological crystallography.

[28]  S. Ha,et al.  Crystal Structure of the Protease Domain of a Heat-shock Protein HtrA from Thermotoga maritima * , 2003, The Journal of Biological Chemistry.

[29]  A. Basilevsky,et al.  Factor Analysis as a Statistical Method. , 1964 .

[30]  Emad S. Alnemri,et al.  Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi , 2002, Nature Structural Biology.

[31]  R. Sauer,et al.  Allosteric Activation of DegS, a Stress Sensor PDZ Protease , 2007, Cell.

[32]  M. DeWitt,et al.  Distance mapping in proteins using fluorescence spectroscopy: the tryptophan-induced quenching (TrIQ) method. , 2010, Biochemistry.

[33]  P. Evans,et al.  Scaling and assessment of data quality. , 2006, Acta crystallographica. Section D, Biological crystallography.

[34]  B. Winblad,et al.  Association of Omi/HtrA2 with γ-secretase in mitochondria , 2010, Neurochemistry International.

[35]  Peter A. Kollman,et al.  AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules , 1995 .

[36]  L. Martins,et al.  Mitochondrial Quality Control and Parkinson’s Disease: A Pathway Unfolds , 2010, Molecular Neurobiology.

[37]  D. Min,et al.  Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. , 2006, The Journal of biological chemistry.

[38]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[39]  Jorge Nocedal,et al.  On the limited memory BFGS method for large scale optimization , 1989, Math. Program..

[40]  A. Giełdoń,et al.  Intra- and intersubunit changes accompanying thermal activation of the HtrA2(Omi) protease homotrimer. , 2016, Biochimica et biophysica acta.

[41]  J. Hartkamp,et al.  The Wilms' Tumor Suppressor Protein WT1 Is Processed by the Serine Protease HtrA2/Omi , 2010, Molecular cell.

[42]  Philip R. Evans,et al.  How good are my data and what is the resolution? , 2013, Acta crystallographica. Section D, Biological crystallography.

[43]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[44]  J. Sacchettini,et al.  Structure and function of the virulence-associated high-temperature requirement A of Mycobacterium tuberculosis. , 2008, Biochemistry.

[45]  R. Sauer,et al.  Allostery Is an Intrinsic Property of the Protease Domain of DegS , 2010, The Journal of Biological Chemistry.

[46]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[47]  A. Giełdoń,et al.  Temperature-induced changes of HtrA2(Omi) protease activity and structure , 2012, Cell Stress and Chaperones.

[48]  Kevin Skadron,et al.  Scalable parallel programming , 2008, 2008 IEEE Hot Chips 20 Symposium (HCS).

[49]  Jie J. Zheng,et al.  PDZ domains and their binding partners: structure, specificity, and modification , 2010, Cell Communication and Signaling.

[50]  R. Huber,et al.  HTRA proteases: regulated proteolysis in protein quality control , 2011, Nature Reviews Molecular Cell Biology.

[51]  K. Fukunaga,et al.  Mitochondrial serine protease HtrA2/Omi as a potential therapeutic target. , 2009, Current drug targets.

[52]  R. Sauer,et al.  Covalent Linkage of Distinct Substrate Degrons Controls Assembly and Disassembly of DegP Proteolytic Cages , 2011, Cell.

[53]  C. Southan,et al.  Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. , 2000, European journal of biochemistry.

[54]  S. Srinivasula,et al.  The C-terminal Tail of Presenilin Regulates Omi/HtrA2 Protease Activity* , 2004, Journal of Biological Chemistry.

[55]  W. Ju,et al.  Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease , 2008, Proceedings of the National Academy of Sciences.

[56]  Edmund R. Malinowski,et al.  Factor Analysis in Chemistry , 1980 .

[57]  A. Brunger Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. , 1992 .

[58]  P. Vandenabeele,et al.  The mitochondrial serine protease HtrA2/Omi: an overview , 2008, Cell Death and Differentiation.

[59]  Ivet Bahar,et al.  Principal component analysis of native ensembles of biomolecular structures (PCA_NEST): insights into functional dynamics , 2009, Bioinform..

[60]  Levi C. T. Pierce,et al.  Routine Access to Millisecond Time Scale Events with Accelerated Molecular Dynamics , 2012, Journal of chemical theory and computation.

[61]  Nitu Singh,et al.  Allosteric Regulation of Serine Protease HtrA2 through Novel Non-Canonical Substrate Binding Pocket , 2013, PloS one.

[62]  T. Baker,et al.  A conserved activation cluster is required for allosteric communication in HtrA-family proteases. , 2015, Structure.

[63]  J. Ortega,et al.  A new function of human HtrA2 as an amyloid-beta oligomerization inhibitor. , 2009, Journal of Alzheimer's disease : JAD.

[64]  J. Downward,et al.  Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response , 2009, Cell Death and Differentiation.

[65]  Ivet Bahar,et al.  ProDy: Protein Dynamics Inferred from Theory and Experiments , 2011, Bioinform..

[66]  L. Cantley,et al.  Binding Specificity and Regulation of the Serine Protease and PDZ Domains of HtrA2/Omi* , 2003, Journal of Biological Chemistry.

[67]  R. Huber,et al.  HtrA proteases have a conserved activation mechanism that can be triggered by distinct molecular cues , 2010, Nature Structural &Molecular Biology.

[68]  C. Chu,et al.  Mitochondrial quality control: insights on how Parkinson’s disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis , 2009, Journal of bioenergetics and biomembranes.